STP938 Clinical Trials
3 recruitingDrug
Phase 12Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
Essential Thrombocythaemia
Step Pharma, SAS50 enrolled14 locationsNCT06786234
Recruiting
Phase 1
Study of STP938 (Dencatistat) in Advanced Solid Tumours
Solid Tumor
Step Pharma, SAS70 enrolled7 locationsNCT06297525
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Lymphoma, T-CellLymphoma, B-Cell
Step Pharma, SAS180 enrolled15 locationsNCT05463263